1. Alberts DS, Griffith KS, Goodman GE, Herman TS, Murray E (1980) Phase I clinical trial of mitozantrone, a new anthracenedione anticancer drug. Cancer Chemother Pharmacol 5:11?15
2. Alberts DS, Yei-Mei P, Leigh S, Davis TP, Woodward DL (1985) Disposition of mitozantrone in cancer patients. Cancer Res 45:1879?1884
3. Cornbleet MA, Stuart-Harris RC, Smith IE, Coleman RE, Rubens RD, Mouridsen HT, Rainer H, Van Oosterom AT, Smyth JF (1984) Mitozantrone in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol 20:1141?1146
4. Gams RA (1984) Mitozantrone therapy in malignant lymphomas. In: A comprehensive guide to the therapeutic use of novantrone. Pharmalibri, Morristown, pp 107?117
5. Henderson BM, Dougherty WJ, James VC, Tilley LP, Noble JF (1982) Safety assessment of a new anticancer compound, mitozantrone, in beagle dogs: comparison with doxorubicin. Cancer Treatment Rep 66:1139?1143